Article Details
Retrieved on: 2024-12-05 18:59:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Novartis is seeking to prevent the entry of generics for its blockbuster heart failure drug Entresto, its top-selling asset that brought in more ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here